Acute myeloblastic leukaemias and myelodysplastic syndromes in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Fey
M F
MF
Department of Medical Oncology, Inselspital and University of Bern, Switzerland.
Dreyling
M
M
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D005060:Europe / Q000453:epidemiology; D005500:Follow-Up Studies; D006801:Humans; D016130:Immunophenotyping; D015994:Incidence; D007621:Karyotyping; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000628:therapy*; D009190:Myelodysplastic Syndromes / Q000175:diagnosis* / Q000628:therapy*; D011379:Prognosis; D018570:Risk Assessment; D055502:Secondary Prevention; D033581:Stem Cell Transplantation; D016896:Treatment Outcome
D000970:Antineoplastic Agents